Alpha Sense BI

MARCH 13, 2024

Related Reading: How Artificial Intelligence is Reshaping Drug Development Race to Bring GLP-1 Assets to Market According to the Journal of the American Medical Association (JAMA), glucagon-like peptide 1 (GLP-1) agonists are medications approved for the treatment of diabetes that have also recently gained popularity for off-label weight loss.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

SEPTEMBER 15, 2023

Forward-thinking technological advancements such as automation, artificial intelligence (AI), and digital therapeutics have allowed the healthcare industry to transform and grow more rapidly than ever before. Medtech lies at the intersection of two of the most fast-changing and innovative industries—healthcare and technology.

Hospitals 105

Hospitals Due Diligence Innovation Globalization 105

Alpha Sense BI

OCTOBER 6, 2023

Opportunities abound for innovative medical device companies that can create a wearable or biometric device that provides value to consumers, while easing pressure on hospitals and healthcare facilities. This practice can reduce hospital costs by up to 50% and cut ozone depletion by almost 90%.

Hospitals 59

Hospitals Startups Due Diligence Innovation 59

Alpha Sense BI

APRIL 12, 2024

AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Which is why expert calls are interesting.

Primary Research 52

Primary Research Advantage Advantage Research 52